Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
